Modicus Prime, an Austin, TX-based computer vision software provider that automates biologics image analysis, raised $3.5M in Seed funding.
The round was led by Silverton Partners, with participation from Alumni Ventures and others. As part of the financing round, Silverton Partners’ Roger Chen will join the Company’s board of directors.
The company intends to use the funds to further service their international pharmaceutical customers with additional customer support.
Led by CEO Taylor Chartier, Modicus Prime provides computer vision software that automates biologics image analysis and is designed to solve for the cost, legal, and waste liabilities from product quality failures. The cloud software scales GxP-compatible AI models for real-time quality control in commercial manufacturing. As a hardware-agnostic software layer, mpVision is integrated into any camera-equipped device, ranging from microscopes to microflow imaging devices. By ensuring the identity, efficacy, and purity of drug products, mpVision significantly reduces costs and waste from failed batches.
As a Johnson & Johnson JLABS resident at the Texas Medical Center, it is venture-backed and has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory (DOE), Dotmatics, and eLabNext (Eppendorf).
Current implementation areas for the software include biologics, cell and gene therapies, and vaccines for pharmaceutical manufacturing, CMOs, and CDMOs.
FinSMEs
15/07/2024